Important: Formulation and dosage details
Formulation:
Tablets 2mg, 5mg, 10mg
Important: Formulation and dosage details
Formulation:
Oral solution 2mg/5mL
Important: Formulation and dosage details
Formulation:
Rectal solution 5mg/2·5mL, 10mg/2·5mL
test announcement
MHRA alert: Benzodiazepines and opioids - reminder of risk of potentially fatal respiratory depression (March 2020) (www.gov.uk).
Tablets 1mg
Solution for injection 4mg/mL (licensed and unlicensed preparations)
Oromucosal solution 50mg/5mL (Epistatus®) (CD schedule 3) unlicensed
Solution for injection 10mg/2mL, 5mg/5mL (CD schedule 3)
The 10mg/2mL injection is used in Palliative Care as a subcutaneous bolus injection; refer to Scottish Palliative Care Guidelines.
Solution for infusion 50mg/50mL (CD schedule 3)
Nasal solution (midazolam 20mg, lidocaine 10mg/0·5mL (CD schedule 3) unlicensed
For use by anaesthetists only, for the sedation of patients for whom traditional methods of sedation (oral or intravenous) are contraindicated or unsuitable.